Sa1495 - Hbeag Loss and Seroconversion Predictors by Baseline Clinical Features and Viral Deep Sequencing of Treatment with Tenofovir Alafenamide Fumarate (TAF) or Tenofovir Disoproxil Fumarate (TDF) after 144 Weeks
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI